BR0011294A - Gene derivado lawsonia e polipeptìdeos, peptìdeos e proteìnas flge relacionados e seus usos - Google Patents
Gene derivado lawsonia e polipeptìdeos, peptìdeos e proteìnas flge relacionados e seus usosInfo
- Publication number
- BR0011294A BR0011294A BR0011294-1A BR0011294A BR0011294A BR 0011294 A BR0011294 A BR 0011294A BR 0011294 A BR0011294 A BR 0011294A BR 0011294 A BR0011294 A BR 0011294A
- Authority
- BR
- Brazil
- Prior art keywords
- lawsonia
- lawsonia intracellularis
- present
- peptides
- proteins
- Prior art date
Links
- 108090000623 proteins and genes Proteins 0.000 title abstract 6
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 5
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 4
- 102000004169 proteins and genes Human genes 0.000 title abstract 3
- 241001469654 Lawsonia <weevil> Species 0.000 title abstract 2
- 229920001184 polypeptide Polymers 0.000 title abstract 2
- 241001148567 Lawsonia intracellularis Species 0.000 abstract 4
- 208000028774 intestinal disease Diseases 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 244000005700 microbiome Species 0.000 abstract 2
- 238000011321 prophylaxis Methods 0.000 abstract 2
- 238000011282 treatment Methods 0.000 abstract 2
- 241001465754 Metazoa Species 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 229940039227 diagnostic agent Drugs 0.000 abstract 1
- 239000000032 diagnostic agent Substances 0.000 abstract 1
- 230000004727 humoral immunity Effects 0.000 abstract 1
- 230000002163 immunogen Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 244000052769 pathogen Species 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/205—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Campylobacter (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
- C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Genetics & Genomics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Physics & Mathematics (AREA)
- Pain & Pain Management (AREA)
- Biotechnology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Patente de Invenção: "GENE DERIVADO LAWSONIA E POLIPEPTìDEOS, PEPTìDEOS E PROTEìNAS FLGE RELACIONADOS E SEUS USOS". A presente invenção refere-se genericamente a composições terapêuticas para o tratamento e/ou profilaxia de condições de doença intestinal em animais e pássaros causadas por ou exarcebadas por Lawsonia intracellularis ou microorganismos similares ou de outro modo relacionados. Em particular, a presente invenção provê um novo gene derivado de Lawsonia intracellularis que codifica um peptídeo, polipeptídeo ou proteína FigE imunogênico que é particularmente útil comoum antígeno em preparação de vacina para conferir imunidade humoral contra Lawsonia intracellularis e patógenos relacionados emanimais hospedeiros. A presente invenção é também direcionada a métodos para o tratamento e/ou profilaxia de tais condições de doença intestinal e a agentes diagnósticos e procedimentos para deteção de Lawsonia intracellularis ou microorganismos similares ou de outro modo relacionados.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13397399P | 1999-05-13 | 1999-05-13 | |
PCT/AU2000/000437 WO2000069904A1 (en) | 1999-05-13 | 2000-05-11 | LAWSONIA DERIVED GENE AND RELATED FlgE POLYPEPTIDES, PEPTIDES AND PROTEINS AND THEIR USES |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0011294A true BR0011294A (pt) | 2002-02-26 |
Family
ID=22461178
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0011294-1A BR0011294A (pt) | 1999-05-13 | 2000-05-11 | Gene derivado lawsonia e polipeptìdeos, peptìdeos e proteìnas flge relacionados e seus usos |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP1181315A4 (pt) |
JP (1) | JP2003516113A (pt) |
AU (1) | AU771376B2 (pt) |
BR (1) | BR0011294A (pt) |
CA (1) | CA2372098A1 (pt) |
MX (1) | MXPA01011669A (pt) |
NZ (1) | NZ515331A (pt) |
PE (1) | PE20010316A1 (pt) |
WO (1) | WO2000069904A1 (pt) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6605696B1 (en) | 1999-10-22 | 2003-08-12 | Pfizer, Inc. | Lawsonia intracellularis proteins, and related methods and materials |
EP1586646B1 (en) | 2000-12-20 | 2011-03-09 | Intervet International BV | Lawsonia intracellularis vaccine |
BRPI0413857A (pt) * | 2003-09-12 | 2006-10-24 | Akzo Nobel Nv | seqüência de ácido nucleico, fragmento de dna, molécula de dna recombinante, veìculo recombinante vivo, célula hispedeira, proteìna de lawsonia intracellularis, uso de uma proteìna de lawsonia intracellularis, vacina para combater infecções por lawsonia intracellularis, método para a preparação de uma vacina, e, teste diagnóstico |
US8834891B2 (en) | 2005-03-14 | 2014-09-16 | Boehringer Ingelheim Vetmedica, Inc. | Immunogenic compositions comprising Lawsonia intracellularis |
US8398994B2 (en) | 2005-07-15 | 2013-03-19 | Boehringer Ingelheim Vetmedica, Inc. | Lawsonia vaccine and methods of use thereof |
US20100129397A1 (en) | 2006-12-11 | 2010-05-27 | Boehringer Ingelheim Vetmedica, Inc. | Effective method of treatment of porcine circovirus and lawsonia intracellularis infections |
CN114712392B (zh) * | 2022-05-16 | 2022-11-25 | 西部医美生物科技成都有限公司双流医疗分公司 | 来自自体血液分离的免疫细胞制剂及其应用 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5885823A (en) * | 1995-06-05 | 1999-03-23 | Nobl Laboratories, Inc. | Lawsonia intracellularis cultivation, anti-Lawsonia intracellularis vaccines and diagnostic agents |
NZ322398A (en) * | 1995-11-30 | 2000-02-28 | Pig Res & Dev Corp | Vaccine compositions comprising non-pathogenic form of Lawsonia intracellularis, nucleic acid sequences thereof and treatment of intestinal disease |
-
2000
- 2000-05-11 MX MXPA01011669A patent/MXPA01011669A/es unknown
- 2000-05-11 NZ NZ515331A patent/NZ515331A/en unknown
- 2000-05-11 CA CA002372098A patent/CA2372098A1/en not_active Abandoned
- 2000-05-11 BR BR0011294-1A patent/BR0011294A/pt not_active IP Right Cessation
- 2000-05-11 WO PCT/AU2000/000437 patent/WO2000069904A1/en not_active Application Discontinuation
- 2000-05-11 EP EP00924976A patent/EP1181315A4/en not_active Withdrawn
- 2000-05-11 JP JP2000618320A patent/JP2003516113A/ja active Pending
- 2000-05-11 AU AU43859/00A patent/AU771376B2/en not_active Ceased
- 2000-05-12 PE PE2000000446A patent/PE20010316A1/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
JP2003516113A (ja) | 2003-05-13 |
AU771376B2 (en) | 2004-03-18 |
NZ515331A (en) | 2003-07-25 |
CA2372098A1 (en) | 2000-11-23 |
EP1181315A4 (en) | 2002-08-14 |
PE20010316A1 (es) | 2001-03-15 |
MXPA01011669A (es) | 2003-09-10 |
WO2000069904A1 (en) | 2000-11-23 |
EP1181315A1 (en) | 2002-02-27 |
AU4385900A (en) | 2000-12-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2006206577B2 (en) | Polypeptides for inducing a protective immune response against Staphylococcus aureus | |
RU2757426C2 (ru) | Иммунногенный слитый белок | |
BRPI0407877A (pt) | conjugado de peptìdeo-proteìna, vacina para a prevenção ou melhora da infecção pelo vìrus influenza, e, método para induzir um resposta imune em um paciente | |
PT1090033E (pt) | Particulas de proteinas de envelope do hcv: utilizacao para vacinacao | |
CA3145228A1 (en) | African swine fever vaccine | |
CN105142653B (zh) | 增强对肠病原体免疫应答的组合物和方法 | |
CN107266582A (zh) | 牙龈卟啉单胞菌感染的预防、治疗和诊断 | |
US20090088390A1 (en) | Polypeptide | |
BR0011292A (pt) | Gene derivado de lawsonia e proteìnas, peptìdeos e polipeptìdeos sodc relacionados e seus usos | |
CN103533953A (zh) | 针对肺炎链球菌的疫苗 | |
BR0011294A (pt) | Gene derivado lawsonia e polipeptìdeos, peptìdeos e proteìnas flge relacionados e seus usos | |
BR0011290A (pt) | Gene derivado de lawsonia e polipeptìdeos, peptìdeos e proteìnas de omph relacionados e seus usos | |
BR112022020438A2 (pt) | Composições compreendendo três proteínas de fusão ospa para uso médico | |
CN102488898B (zh) | 龋齿疫苗及制备方法 | |
PT680765E (pt) | Vacina para estirpe não tipável de haemophilus influenzae. | |
US20110020356A1 (en) | Therapeutic clostridium difficile antibody compositions | |
BR9916549A (pt) | Composição farmacêutica, vacina, proteìna, e, método para a prevenção ou tratamento de leishmaniose em um humano ou animal | |
US20030220265A1 (en) | Dihydroxypropyl cysteine peptide and agent containing this peptide | |
WO2004022092A3 (en) | Flagellin peptides as adjuvants for vaccines | |
BR0114835A (pt) | Composições terapêuticas para tratamento de infecção por lawsonia spp | |
ES2253784T3 (es) | Nuevo polipeptido extraido de hemophilus paragallinarum y su procedimiento de produccion. | |
NZ507983A (en) | A polypeptide comprising the amino acid of an n- terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof | |
US20240173394A1 (en) | Immunogenic fusion protein | |
RU2003107837A (ru) | Гены и белки и их применения | |
BRPI0417798A (pt) | proteìna de membrana externa de 72 kda de brachyspira pilosicoli e usos diagnósticos e terapêuticos da mesma |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 7O, 8O E 9O ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 DA RPI 2008 DE 30/06/2009. |